|
|
||||||||||||||
|
|
|||||||||||||||
Diagnosis |
Clinical impact ratings GP/FP/Primary care






Obstetrics 





Endocrine 





Nephrology 





Key Words: diabetes mellitus (type 1) pregnancy pre-eclampsia diabetic nephropathies
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
prospective cohort study.
Setting:
university hospital in Copenhagen, Denmark.
Patients:
119 pregnant women (mean age 30 y) with type 1 diabetes who were enrolled at <14 weeks gestation.
Description of test:
median albumin to creatinine ratio in 2 (or 3 if there was disagreement between the first 2) random urine samples taken at 722 weeks gestation, with no restrictions on time of day, diet, or exercise. Microalbuminuria was defined as 2.5 or 3.525 mg/mmol (21 or 30210 µg/mg creatinine) and macroalbuminuria as >25 mg/mmol (>210 µg/mg creatinine).
Diagnostic standard:
median albumin excretion (measured by enzyme linked immunosorbent assay) in two 24 hour urine collections. Microalbuminuria was defined as 30300 mg/24 h and macroalbuminuria as >300 mg/24 h.
Outcomes:
sensitivity, specificity, and likelihood ratios.
MAIN RESULTS
Based on the 24 hour urine collections, microalbuminuria was present in 7 women (5.9%) and macroalbuminuria in 9 women (7.6%). The correlation coefficient between the 24
Chris L Bryson, MD, MS, Lorien Dalrymple, MD, MPH
Health Services Research and Development, Seattle,
Washington, USA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |